B.S. Thippeswamy

1.7k total citations
62 papers, 1.3k citations indexed

About

B.S. Thippeswamy is a scholar working on Molecular Biology, Plant Science and Toxicology. According to data from OpenAlex, B.S. Thippeswamy has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Plant Science and 11 papers in Toxicology. Recurrent topics in B.S. Thippeswamy's work include Natural Antidiabetic Agents Studies (11 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Medicinal Plants and Neuroprotection (4 papers). B.S. Thippeswamy is often cited by papers focused on Natural Antidiabetic Agents Studies (11 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Medicinal Plants and Neuroprotection (4 papers). B.S. Thippeswamy collaborates with scholars based in India, Saudi Arabia and Eritrea. B.S. Thippeswamy's co-authors include Veeresh Prabhakar Veerapur, Shrishailappa Badami, Pandian Nagakannan, Mahendran Sekar, Punit Bansal, M.K. Unnikrishnan, Shivsharan B. Dhadde, K Prabhakar, Kalyani Srinivasan and K Manjunath and has published in prestigious journals such as Food Chemistry, International Journal of Molecular Sciences and International Journal of Pharmaceutics.

In The Last Decade

B.S. Thippeswamy

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.S. Thippeswamy India 21 423 228 211 210 199 62 1.3k
Altaf S. Darvesh United States 28 893 2.1× 270 1.2× 128 0.6× 168 0.8× 151 0.8× 45 2.4k
Veeresh Prabhakar Veerapur India 28 578 1.4× 538 2.4× 261 1.2× 389 1.9× 337 1.7× 70 2.0k
Martina Blunder Austria 17 664 1.6× 157 0.7× 91 0.4× 88 0.4× 136 0.7× 23 1.3k
Silvio Chericoni Italy 17 377 0.9× 277 1.2× 65 0.3× 150 0.7× 79 0.4× 37 1.1k
Lucia Račková Slovakia 22 488 1.2× 229 1.0× 59 0.3× 116 0.6× 132 0.7× 48 1.7k
Ghulam Abbas Pakistan 20 246 0.6× 265 1.2× 52 0.2× 173 0.8× 177 0.9× 74 1.1k
Shrishailappa Badami India 27 652 1.5× 729 3.2× 263 1.2× 332 1.6× 261 1.3× 75 2.0k
Gowhar Ali Pakistan 18 329 0.8× 205 0.9× 41 0.2× 193 0.9× 91 0.5× 78 1.2k
Sally A. El Awdan Egypt 24 365 0.9× 142 0.6× 41 0.2× 153 0.7× 119 0.6× 70 1.5k
Emily Pansera Waczuk Brazil 20 226 0.5× 323 1.4× 160 0.8× 125 0.6× 42 0.2× 31 1.0k

Countries citing papers authored by B.S. Thippeswamy

Since Specialization
Citations

This map shows the geographic impact of B.S. Thippeswamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.S. Thippeswamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.S. Thippeswamy more than expected).

Fields of papers citing papers by B.S. Thippeswamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.S. Thippeswamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.S. Thippeswamy. The network helps show where B.S. Thippeswamy may publish in the future.

Co-authorship network of co-authors of B.S. Thippeswamy

This figure shows the co-authorship network connecting the top 25 collaborators of B.S. Thippeswamy. A scholar is included among the top collaborators of B.S. Thippeswamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.S. Thippeswamy. B.S. Thippeswamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahesh, B., et al.. (2025). Combined in vitro and in silico approach to define alangimarckine from Thunbergia mysorensis leaves as a potential inhibitor of α-glucosidase. Journal of Biomolecular Structure and Dynamics. 43(18). 10878–10897.
2.
Rahamathulla, Mohamed, Sushma Devi, Manish Kumar, et al.. (2025). IRES activation: HK2 and TPI1 glycolytic enzymes play a pivotal role in non-neuronal cell survival under hypoxia. Artificial Cells Nanomedicine and Biotechnology. 53(1). 139–152. 1 indexed citations
3.
Rahamathulla, Mohamed, Mohammed Muqtader Ahmed, Syeda Ayesha Farhana, et al.. (2024). Box-Behnken Design-Based Optimization and Evaluation of Lipid-Based Nano Drug Delivery System for Brain Targeting of Bromocriptine. Pharmaceuticals. 17(6). 720–720. 12 indexed citations
5.
Alhamhoom, Yahya, H.N. Shivakumar, Mohamed Rahamathulla, et al.. (2024). Sublingual Fast-Dissolving Thin Films of Loratadine: Characterization, In Vitro and Ex Vivo Evaluation. Polymers. 16(20). 2919–2919. 3 indexed citations
7.
Thippeswamy, B.S., et al.. (2020). Fumaric acid protect the cadmium-induced hepatotoxicity in rats: owing to its antioxidant, anti-inflammatory action and aid in recast the liver function. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(10). 1911–1920. 37 indexed citations
8.
Durg, Sharanbasappa, et al.. (2017). Antipsychotic activity of embelin isolated from Embelia ribes: A preliminary study. Biomedicine & Pharmacotherapy. 90. 328–331. 21 indexed citations
9.
Dhadde, Shivsharan B., et al.. (2017). Ameliorative effect of chromium-d-phenylalanine complex on indomethacin-induced inflammatory bowel disease in rats. Biomedicine & Pharmacotherapy. 89. 1061–1066. 34 indexed citations
10.
Dhadde, Shivsharan B., Pandian Nagakannan, M. S. Roopesh, et al.. (2015). Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats. Biomedicine & Pharmacotherapy. 77. 52–58. 73 indexed citations
11.
Dhadde, Shivsharan B., et al.. (2014). Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice. Toxicology Mechanisms and Methods. 24(9). 672–678. 18 indexed citations
12.
Manjunath, K, et al.. (2014). Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection – Preparation, characterisation and in vivo evaluation. International Journal of Pharmaceutics. 473(1-2). 485–492. 58 indexed citations
13.
Krishna, V., et al.. (2012). Anticonvulsant activity of Erythrina mysorensis bark extract in an animal model of epilepsy. Journal of Pharmacology and Pharmacotherapeutics. 3(1). 62–64. 5 indexed citations
14.
Nagakannan, Pandian, et al.. (2012). Protective effect of hydroalcoholic extract of Mimusops elengi Linn. flowers against middle cerebral artery occlusion induced brain injury in rats. Journal of Ethnopharmacology. 140(2). 247–254. 28 indexed citations
15.
Veerapur, Veeresh Prabhakar, et al.. (2012). Anti-diabetic and anti-cataract effects of Chromolaena odorata Linn., in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology. 145(1). 363–372. 46 indexed citations
16.
Thippeswamy, B.S., et al.. (2011). Protective Effect of Embelin from Embelia ribes Burm. Against Transient Global Ischemia-Induced Brain Damage in Rats. Neurotoxicity Research. 20(4). 379–386. 48 indexed citations
17.
Mahmood, Riaz, et al.. (2010). Hepatoprotective and antioxidant effect of Azima tetracantha Lam. leaves extracts against CCl 4- induced liver injury in rats. Indian Journal of Natural Products and Resources. 1(4). 493–499. 3 indexed citations
18.
Thippeswamy, B.S., et al.. (2010). Evaluation of antipyretic activity of Azima tetracantha Lam. in rats. Biotechnology : an Indian journal. 4(1). 1 indexed citations
19.
Thippeswamy, B.S., et al.. (2010). Anti-inflammatory and analgesic activities of Azima tetracantha Lam leaves.. Journal of Pharmacy Research. 3(3). 478–481. 3 indexed citations
20.
Sekar, Mahendran, B.S. Thippeswamy, Veeresh Prabhakar Veerapur, & Shrishailappa Badami. (2010). Anticonvulsant activity of embelin isolated from Embelia ribes. Phytomedicine. 18(2-3). 186–188. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026